The infections were reported by Arkansas, Wisconsin, and Manitoba, Canada.
Listen to a recording of our Dec 3, 2025, webinar on vertical CWD transmission. Experts discussed the implications of vertical transmission for free-ranging white-tailed deer herds, and Cory Anderson, PhD, MPH, of CIDRAP's CWD team, moderated a Q&A session after the discussion.
The report provides useful guidance to professionals at human, animal, and wildlife health agencies; academic researchers; and medical practitioners who will be tasked with responding to any human or non-cervid animal chronic wasting disease spillover.
The CIDRAP CWD Resource Center hosts webinars featuring natural and international experts.
Our monthly roundup features the latest CWD-related news, research, and events.
Stay in touch with CIDRAP CWD via X for the latest news and research.
Keep current with CIDRAP CWD news and research on Bluesky.
Receive CWD updates in your inbox
A third Pfizer COVID-19 vaccine dose is 92% more effective in reducing severe COVID-related outcomes than two doses of the same vaccine received at least 5 months previously, according to a large real-world study late last week in The Lancet.
First responders' risk for COVID-19 infection is about 60% more than other essential workers, including healthcare workers (HCWs), according to a study published late last week in JAMA Health Forum.
People with mental disorders and intellectual disabilities had a greater mortality risk during the COVID-19 pandemic in 2020, according to a study published late last week in The Lancet Regional Health – Europe.
The World Health Organization (WHO) today recommended the RTS,S malaria vaccine for children in sub-Saharan Africa and other areas of moderate and high Plasmodium falciparum malaria transmission. The recommendation paves the way for global health groups to make funding and vaccine rollout plans and for countries to decide whether to include vaccination in their malaria control programs.
Critically ill COVID-19 patients who received extracorporeal membrane oxygenation (ECMO) at the end of 2020 had a higher mortality rate than those who received it in the first half of the year, according to a study published yesterday in The Lancet.
Seven COVID-19 symptoms can maximize detection of COVID-19 in the community, according to a large study published in PLOS Medicine yesterday that looked at data from England's REal-time Assessment of Community Transmission-1 (REACT-1) study.
A review and meta-analysis of point-prevalence surveys conducted in Asia over the past two decades found concerning levels of resistance to first-line and last-resort antibiotics in foodborne pathogens isolated from aquatic animals, researchers reported late last week in Nature Communications.
US counties with more excess deaths not attributed to COVID-19 had less health insurance coverage and primary care as well as more at-home deaths, according to a research letter today in JAMA Network Open.
The researchers looked at 2020 data from the US National Center for Health Statistics for 2,096 counties with 319.1 million residents and divided county characteristics into quartiles.
A survey across 73 countries assessing the impact of COVID-19 on the prevention and control of antimicrobial resistance (AMR) highlights reduced availability of nursing, medical, and public health staff for AMR efforts. The study was published today in the Journal of Antimicrobial Chemotherapy.
The rheumatoid arthritis drug baricitinib was shown to reduce mortality in hospitalized COVID-19 patients, according to a randomized, controlled trial published in The Lancet Respiratory Medicine yesterday. Baricitinib acts as a Janus kinases inhibitor and is under emergency use authorization to treat severe COVID-19 by the US Food and Drug Administration.
